表紙
市場調查報告書

全球體內CRO市場規模,佔有率,趨勢分析:各產品,GLP各類型,各適應症(糖尿病,肥胖,自體免疫/發炎,中樞神經疾病),市場區隔預測

In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026

出版商 Grand View Research, Inc. 商品編碼 818733
出版日期 內容資訊 英文 170 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球體內CRO市場規模,佔有率,趨勢分析:各產品,GLP各類型,各適應症(糖尿病,肥胖,自體免疫/發炎,中樞神經疾病),市場區隔預測 In vivo CRO Market Size, Share & Trends Analysis Report By Product Type, By GLP Type, By Indication (Diabetes, Obesity, Autoimmune/Inflammatory, CNS Conditions), And Segment Forecasts, 2019 - 2026
出版日期: 2019年03月27日內容資訊: 英文 170 Pages
簡介

本報告提供全球體內CRO市場相關調查,彙整市場趨勢與各市場區隔趨勢,各地區預測,加入此市場的主要企業簡介等相關資訊。

第1章 調查範圍

第2章 調查方法

第3章 調查目的

第4章 摘要整理

第5章 市場變數,趨勢,範圍

  • 市場直線預測
  • 滲透度與成長預測製圖
  • 產品平台分析
  • 用戶展望分析
  • 各地區,各產品,各國主要終端用戶清單
  • 相關法規
  • 市場變數分析
    • 推動市場的要素分析
    • 阻礙市場的要素分析
    • 市場課題
  • 市場分析工具

第6章 各類服務市場區隔分析

  • 定義和範圍
  • 市場區隔概要
  • 市場佔有率分析
  • 嚙齒動物為主
  • 非嚙齒動物為主

第7章 各類型市場區隔分析

  • 定義和範圍
  • 市場區隔概要
  • 市場佔有率分析
  • 非GLP
  • GLP毒理學

第8章 各適應症市場區隔分析

  • 定義和範圍
  • 市場區隔概要
  • 市場佔有率分析
  • 自體免疫疾病/發炎性疾病
  • 疼痛管理
  • 腫瘤
  • 中樞神經疾病
  • 糖尿病
  • 肥胖
  • 其他

第9章 各地區分析

  • 定義和範圍
  • 市場概要
  • 各地區市場佔有率和主要企業
  • SWOT分析
  • 市場佔有率分析
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第10章 競爭分析

  • 近幾年的發展及影響分析
  • 企業/競爭分類
  • 供應商環境
  • 公共企業
  • 民營企業
  • 供應商排行榜

第11章 企業簡介

  • 策略性架構

第12章 KOL評論

第13章 建議

目錄
Product Code: GVR-1-68038-011-8

The global in vivo cro market is anticipated to reach USD 5.81 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.

In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.

Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor USD 3.3 billion. The patent cliff, high research and development cost involved, and globalization in the clinical trial process has driven the

Further key findings from the report suggest:

  • Rodent based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice is the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.
  • Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects
  • North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs
  • Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth

Some of the key market players include: Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players

Table of Contents

Chapter 1 Report Scope

  • 1.1 Segment Market Scope
  • 1.2 Regional Scope

Chapter 2 Methodology

  • 2.1 Research Methodology
    • 2.1.1 Information Procurement
  • 2.2 Information Or Data Analysis
  • 2.3 Market Formulation & Validation
  • 2.4 Region Wise Market Calculation
    • 2.4.1 Region Wise Market: Base Estimates
    • 2.4.2 Global Market: CAGR Calculation
  • 2.5 Region Based Segment Share Calculation
  • 2.6 Model Details
    • 2.6.1 Commodity Flow Analysis (Model 1)
    • 2.6.2 Volume Price Analysis (Model 2)
  • 2.7 List Of Secondary Sources
  • 2.8 List Of Primary Sources
  • 2.9 List Of Abbreviations

Chapter 3 Objectives

  • 3.1 Objective - 1:
  • 3.2 Objective - 2:
  • 3.3 Objective - 3:
  • 3.4 Objective - 4:

Chapter 4 Executive Summary

  • 4.1 Market Outlook
  • 4.2 Segment Outlook
  • 4.3 Competitive Insights

Chapter 5 In Vivo CRO Market: Variables, Trends & Scope

  • 5.1 Market Lineage Outlook
    • 5.1.1 Parent Market Outlook
    • 5.1.2 Ancillary Market Outlook
  • 5.2 Penetration & Growth Prospect Mapping
  • 5.3 Product Pipeline Analysis, By Stage
  • 5.4 User Perspective Analysis
    • 5.4.1 Consumer Behavior Analysis
    • 5.4.2 Market Influencer Analysis
  • 5.5 List Of Key End-Users, By Region / By Product / By Country
  • 5.6 Regulatory Framework
    • 5.6.1 Reimbursement Framework
    • 5.6.2 Standards & Compliances
  • 5.7 Market Variable Analysis
    • 5.7.1 Market Driver Analysis
      • 5.7.1.1 Changing Regulatory Landscape
      • 5.7.1.2 Increase In Offshoring Medical Device Manufacturing To Emerging Countries
      • 5.7.1.3 Rising Demand For Advanced Products
      • 5.7.1.4 Implementation Of International Standards By Contract Manufacturers
      • 5.7.1.5 Rising Price Competition And Requirement To Reduce Cost
      • 5.7.1.6 Increasing Complexity With Respect To Product Design And Engineering
    • 5.7.2 Market Restraint Analysis
      • 5.7.2.1 Compliance Issues While Outsourcing
      • 5.7.2.2 Changing Scenarios In Developing Countries
      • 5.7.2.3 Regulatory And Legal Compliance
      • 5.7.2.4 Contractual Obligation
    • 5.7.3 Industry Challenges
  • 5.8 In Vivo CRO Market: Analysis Tools
    • 5.8.1 Porter's Five Forces Analysis
    • 5.8.2 Pestel Analysis
    • 5.8.3 Major Deals & Strategic Alliances Analysis
      • 5.8.3.1 Joint Ventures
      • 5.8.3.2 Mergers & Acquisitions
      • 5.8.3.3 Licensing & Partnership
      • 5.8.3.4 Technology Collaborations
      • 5.8.3.5 Strategic Divestments
    • 5.8.4 Market Entry Strategies

Chapter 6 In Vivo CRO Market: Services Segment Analysis

  • 6.1 In Vivo CRO Market: Definition & Scope
  • 6.2 In Vivo CRO Market: Segment Dashboard
  • 6.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
  • 6.4 Rodent Based In Vivo GLP Type
    • 6.4.1 Rodent Based In Vivo GLP Type Market, 2014 - 2026 (USD Billion)
    • 6.4.2 Rats Based In Vivo CRO
      • 6.4.2.1 Rats Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 6.4.3 Mice Based In Vivo CRO
      • 6.4.3.1 Mice Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 6.4.4 Others
      • 6.4.4.1 Others Market, 2014 - 2026 (USD Billion)
  • 6.5 Non-Rodent Based In Vivo GLP Type
    • 6.5.1 Non-Rodent Based In Vivo GLP Type Market, 2014 - 2026 (USD Billion)
    • 6.5.2 Hamsters Based In Vivo CRO
      • 6.5.2.1 Hamsters Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 6.5.3 Guinea Pigs Based In Vivo CRO
      • 6.5.3.1 Guinea Pigs Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 6.5.4 Gerbils Based In Vivo CRO
      • 6.5.4.1 Gerbils Based In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 6.5.5 Others Based In Vivo CRO
      • 6.5.5.1 Others Based In Vivo CRO Market, 2014 - 2026 (USD Billion)

Chapter 7 In Vivo CRO Market: Type Segment Analysis

  • 7.1 In Vivo CRO Market: Definition & Scope
  • 7.2 In Vivo CRO Market: Segment Dashboard
  • 7.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
  • 7.4 Non GLP
    • 7.4.1 Non GLP Market, 2014 - 2026 (USD Billion)
    • 7.4.2 In House
      • 7.4.2.1 In House Market, 2014 - 2026 (USD Billion)
    • 7.4.3 Outsourcing
      • 7.4.3.1 Outsourcing Market, 2014 - 2026 (USD Billion)
  • 7.5 GLP Toxicology
    • 7.5.1 GLP Toxicology Market, 2014 - 2026 (USD Billion)
    • 7.5.2 In House
      • 7.5.2.1 In House Market, 2014 - 2026 (USD Billion)
    • 7.5.3 Outsourcing
      • 7.5.3.1 Outsourcing Market, 2014 - 2026 (USD Billion)

Chapter 8 In Vivo CRO Market: Indication Segment Analysis

  • 8.1 In Vivo CRO Market: Definition & Scope
  • 8.2 In Vivo CRO Market: Segment Dashboard
  • 8.3 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
  • 8.4 Autoimmune/ Inflammatory Conditions
    • 8.4.1 Autoimmune/ Inflammatory Conditions Market, 2014 - 2026 (USD Billion)
    • 8.4.2 Rheumatoid Arthritis
      • 8.4.2.1 Rheumatoid Arthritis Market, 2014 - 2026 (USD Billion)
    • 8.4.3 Multiple Sclerosis
      • 8.4.3.1 Multiple Sclerosis Market, 2014 - 2026 (USD Billion)
    • 8.4.4 Osteoarthritis
      • 8.4.4.1 Osteoarthritis Market, 2014 - 2026 (USD Billion)
    • 8.4.5 Irritable Bowel Syndrome
      • 8.4.5.1 Irritable Bowel Syndrome Market, 2014 - 2026 (USD Billion)
    • 8.4.6 Others
      • 8.4.6.1 Others Market, 2014 - 2026 (USD Billion)
  • 8.5 Pain Management
    • 8.5.1 Pain Management Market, 2014 - 2026 (USD Billion)
    • 8.5.2 Chronic Pain
      • 8.5.2.1 Chronic Pain Market, 2014 - 2026 (USD Billion)
    • 8.5.3 Acute Pain
      • 8.5.3.1 Acute Pain Market, 2014 - 2026 (USD Billion)
  • 8.6 Oncology
    • 8.6.1 Oncology Market, 2014 - 2026 (USD Billion)
    • 8.6.2 Blood Cancer
      • 8.6.2.1 Blood Cancer Market, 2014 - 2026 (USD Billion)
    • 8.6.3 Solid Tumor
      • 8.6.3.1 Solid Tumor Market, 2014 - 2026 (USD Billion)
      • 8.6.3.2 Syngeneic Model
      • 8.6.3.2.1 Syngeneic Model Market, 2014 - 2026 (USD Billion)
      • 8.6.3.3 Patient Derived Xenograft
      • 8.6.3.3.1 Patient Derived Xenograft Market, 2014 - 2026 (USD Billion)
      • 8.6.3.4 Xenograft
      • 8.6.3.4.1 Xenograft Market, 2014 - 2026 (USD Billion)
    • 8.6.4 Others
      • 8.6.4.1 Others Market, 2014 - 2026 (USD Billion)
  • 8.7 CNS Conditions
    • 8.7.1 CNS Conditions Market, 2014 - 2026 (USD Billion)
    • 8.7.2 Epilepsy
      • 8.7.2.1 Epilepsy Market, 2014 - 2026 (USD Billion)
    • 8.7.3 Parkinson's Disease
      • 8.7.3.1 Parkinson's Disease Market, 2014 - 2026 (USD Billion)
    • 8.7.4 Huntington's Disease
      • 8.7.4.1 Huntington's Disease Market, 2014 - 2026 (USD Billion)
    • 8.7.5 Stroke
      • 8.7.5.1 Stroke Market, 2014 - 2026 (USD Billion)
    • 8.7.6 Traumatic Brain Injury
      • 8.7.6.1 Traumatic Brain Injury Market, 2014 - 2026 (USD Billion)
    • 8.7.7 ALS
      • 8.7.7.1 ALS Market, 2014 - 2026 (USD Billion)
    • 8.7.8 Muscle Regeneration
      • 8.7.8.1 Muscle Regeneration Market, 2014 - 2026 (USD Billion)
    • 8.7.9 Others
      • 8.7.9.1 Others Market, 2014 - 2026 (USD Billion)
  • 8.8 Diabetes
    • 8.8.1 Diabetes Market, 2014 - 2026 (USD Billion)
  • 8.9 Obesity
    • 8.9.1 Obesity Market, 2014 - 2026 (USD Billion)
  • 8.10 Others
    • 8.10.1 Others Market, 2014 - 2026 (USD Billion)

Chapter 9 In Vivo CRO Market: Regional Analysis

  • 9.1 In Vivo CRO Market: Definition & Scope
  • 9.2 Regional Market Snapshot
  • 9.3 Regional Market Share And Leading Players, 2018
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 Asia Pacific
    • 9.3.4 Latin America
    • 9.3.5 Middle East & Africa
  • 9.4 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
    • 9.4.1 North America
    • 9.4.2 Europe
    • 9.4.3 Asia Pacific
    • 9.4.4 Latin America
    • 9.4.5 Middle East & Africa
  • 9.5 In Vivo CRO Market: Market Share Analysis, 2018 & 2026
  • 9.6 North America
    • 9.6.1 North America In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.6.2 U.S.
      • 9.6.2.1 U.S. In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.6.3 Canada
      • 9.6.3.1 Canada In Vivo CRO Market, 2014 - 2026 (USD Billion)
  • 9.7 Europe
    • 9.7.1 Europe In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.7.2 France
      • 9.7.2.1 France In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.7.3 U.K.
      • 9.7.3.1 U.K. In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.7.4 Germany
      • 9.7.4.1 Germany In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.7.5 Italy
      • 9.7.5.1 Italy In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.7.6 Spain
      • 9.7.6.1 Spain In Vivo CRO Market, 2014 - 2026 (USD Billion)
  • 9.8 Asia Pacific
    • 9.8.1 Asia Pacific In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.8.2 Japan
      • 9.8.2.1 Japan In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.8.3 China
      • 9.8.3.1 China In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.8.4 India
      • 9.8.4.1 India In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.8.5 Australia
      • 9.8.5.1 Australia In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.8.6 South Korea
      • 9.8.6.1 South Korea In Vivo CRO Market, 2014 - 2026 (USD Billion)
  • 9.9 Latin America
    • 9.9.1 Latin America In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.9.2 Brazil
      • 9.9.2.1 Brazil In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.9.3 Mexico
      • 9.9.3.1 Mexico In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.9.4 Argentina
      • 9.9.4.1 Argentina In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.9.5 Colombia
      • 9.9.5.1 Colombia In Vivo CRO Market, 2014 - 2026 (USD Billion)
  • 9.10 MEA
    • 9.10.1 MEA In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.10.2 South Africa
      • 9.10.2.1 South Africa In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.10.3 Saudi Arabia
      • 9.10.3.1 Saudi Arabia In Vivo CRO Market, 2014 - 2026 (USD Billion)
    • 9.10.4 UAE
      • 9.10.4.1 UAE In Vivo CRO Market, 2014 - 2026 (USD Billion)

Chapter 10 Competitive Analysis

  • 10.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 10.3 Vendor Landscape
    • 10.3.1 List Of Key Distributors And Channel Partners
    • 10.3.2 Key Customers
    • 10.3.3 Key Company Market Share Analysis, 2018
  • 10.4 Public Companies
    • 10.4.1 Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)
    • 10.4.2 Company Market Share/Ranking, By Region
    • 10.4.3 Competitive Dashboard Analysis
      • 10.4.3.1 Market Differentiators
      • 10.4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
  • 10.5 Private Companies
    • 10.5.1 List Of Key Emerging Companies' /Technology Disruptors/Innovators
    • 10.5.2 Funding Outlook (Optional)
    • 10.5.3 Regional Network Map
    • 10.5.4 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
  • 10.6 Supplier Ranking

Chapter 11 Company Profiles

  • 11.1 Strategic Framework
    • 11.1.1 QUINTILES
      • 11.1.1.1 Company Overview
      • 11.1.1.2 Financial Performance
      • 11.1.1.3 Service Benchmarking
      • 11.1.1.4 Strategic Initiatives
    • 11.1.2 CHARLES RIVER LABORATORIES
      • 11.1.2.1 Company Overview
      • 11.1.2.2 Financial Performance
      • 11.1.2.3 Service Benchmarking
    • 11.1.3 ICON PLC
      • 11.1.3.1 Company Overview
      • 11.1.3.2 Financial Performance
      • 11.1.3.3 Service Benchmarking
      • 11.1.3.4 Strategic Initiatives
    • 11.1.4 COVANCE INC.
      • 11.1.4.1 Company Overview
      • 11.1.4.2 Financial Performance
      • 11.1.4.3 Service Benchmarking
      • 11.1.4.4 Strategic Initiatives
    • 11.1.5 PAREXEL INTERNATIONAL
      • 11.1.5.1 Company Overview
      • 11.1.5.2 Financial Performance
      • 11.1.5.3 Service Benchmarking
      • 11.1.5.4 Strategic Initiatives
    • 11.1.6 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC (PPD)
      • 11.1.6.1 Company Overview
      • 11.1.6.2 Financial Performance
      • 11.1.6.3 Service Benchmarking
      • 11.1.6.4 Strategic Initiatives
    • 11.1.7 THEOREM CLINICAL RESEARCH
      • 11.1.7.1 Company Overview
      • 11.1.7.2 Financial Performance
      • 11.1.7.3 Service Benchmarking
      • 11.1.7.4 Strategic Initiatives
    • 11.1.8 INVENTIV HEALTH
      • 11.1.8.1 Company Overview
      • 11.1.8.2 Financial Performance
      • 11.1.8.3 Service Benchmarking
    • 11.1.9 WUXI APPTEC, INC.
      • 11.1.9.1 Company Overview
      • 11.1.9.2 Financial Performance
      • 11.1.9.3 Service Benchmarking
      • 11.1.9.4 Strategic Initiatives
    • 11.1.10 AMERICAN PRECLINICAL SERVICES, LLC.
      • 11.1.10.1 Company Overview
      • 11.1.10.2 Service Benchmarking
      • 11.1.10.3 Strategic Initiatives
    • 11.1.11 EVOTEC (US), INC.
      • 11.1.11.1 Company Overview
      • 11.1.11.2 Financial Performance
      • 11.1.11.3 Service Benchmarking
      • 11.1.11.4 Strategic Initiatives

Chapter 12 KOL Commentary

Chapter 13 Recommendation

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviation
  • Table 3 Leading market players anticipated to witness highest growth
  • Table 5 Global In vivo CRO Market Estimates & Forecasts, by Region, 2014 - 2026 (USD Million)
  • Table 6 Global In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
  • Table 7 Global In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 8 Global Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 9 Global Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 10 Global In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 11 Global Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 12 Global Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 13 Global Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 14 Global Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 15 Global CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 16 Global In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 17 Global GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 18 Global Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 19 Global Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 20 Global Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 21 Global Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 22 Global Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 23 North America In vivo CRO Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
  • Table 24 North America In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
  • Table 25 North America In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 26 North America Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 27 North America Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 28 North America In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 29 North America Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 30 North America Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 31 North America Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 32 North America Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 33 North America CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 34 North America In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 35 North America GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 36 North America Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 37 North America Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 38 North America Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 39 North America Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 40 North America Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 41 U.S. In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 42 U.S. Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 43 U.S. Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 44 U.S. In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 45 U.S. Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 46 U.S. Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 47 U.S. Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 48 U.S. Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 49 U.S. CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 50 U.S. In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 51 U.S. GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 52 U.S. Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 53 U.S. Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 54 U.S. Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 55 U.S. Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 56 U.S. Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 57 Canada In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 58 Canada Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 59 Canada Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 60 Canada In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 61 Canada Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 62 Canada Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 63 Canada Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 64 Canada Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 65 Canada CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 66 Canada In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 67 Canada GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 68 Canada Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 69 Canada Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 70 Canada Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 71 Canada Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 72 Canada Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 73 Europe In vivo CRO Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
  • Table 74 Europe In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
  • Table 75 Europe In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 76 Europe Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 77 Europe Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 78 Europe In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 79 Europe Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 80 Europe Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 81 Europe Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 82 Europe Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 83 Europe CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 84 Europe In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 85 Europe GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 86 Europe Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 87 Europe Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 88 Europe Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 89 Europe Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 90 Europe Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 91 U.K. In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 92 U.K. Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 93 U.K. Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 94 U.K. In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 95 U.K. Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 96 U.K. Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 97 U.K. Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 98 U.K. Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 99 U.K. CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 100 U.K. In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 101 U.K. GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 102 U.K. Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 103 Germany In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 104 Germany Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 105 Germany Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 106 Germany In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 107 Germany Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 108 Germany Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 109 Germany Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 110 Germany Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 111 Germany CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 112 Germany In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 113 Germany GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 114 Germany Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 115 Germany Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 116 Germany Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 117 Germany Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 118 Germany Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 119 France In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 120 France Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 121 France Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 122 France In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 123 France Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 124 France Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 125 France Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 126 France Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 127 France CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 128 France In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 129 France GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 130 France Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 131 France Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 132 France Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 133 France Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 134 France Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 135 Italy In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 136 Italy Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 137 Italy Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 138 Italy In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 139 Italy Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 140 Italy Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 141 Italy Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 142 Italy Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 143 Italy CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 144 Italy In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 145 Italy GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 146 Italy Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 147 Italy Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 148 Italy Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 149 Italy Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 150 Italy Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 151 Spain In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 152 Spain Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 153 Spain Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 154 Spain In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 155 Spain Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 156 Spain Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 157 Spain Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 158 Spain Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 159 Spain CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 160 Spain In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 161 Spain GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 162 Spain Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 163 Spain Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 164 Spain Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 165 Spain Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 166 Spain Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 167 RoE In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 168 RoE Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 169 RoE Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 170 RoE In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 171 RoE Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 172 RoE Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 173 RoE Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 174 RoE Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 175 RoE CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 176 RoE In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 177 RoE GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 178 RoE Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 179 RoE Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 180 RoE Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 181 RoE Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 182 RoE Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 183 Asia Pacific In vivo CRO Market Estimates & Forecasts, by Country, 2014 - 2026 (USD Million)
  • Table 184 Asia Pacific In vivo GLP type CRO Market, by Country 2015 - 2026 (USD Million)
  • Table 185 Asia Pacific In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 186 Asia Pacific Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 187 Asia Pacific Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 188 Asia Pacific In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 189 Asia Pacific Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 190 Asia Pacific Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 191 Asia Pacific Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 192 Asia Pacific Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 193 Asia Pacific CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 194 Asia Pacific In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 195 Asia Pacific GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 196 Asia Pacific Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 197 Asia Pacific Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 198 Asia Pacific Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 199 Asia Pacific Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 200 Asia Pacific Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 201 Japan In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 202 Japan Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 203 Japan Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 204 Japan In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 205 Japan Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 206 Japan Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 207 Japan Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 208 Japan Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 209 Japan CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 210 Japan In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 211 Japan GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 212 Japan Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 213 Japan Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 214 Japan Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 215 Japan Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 216 Japan Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 217 China In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 218 China Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 219 China Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 220 China In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 221 China Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 222 China Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 223 China Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 224 China Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 225 China CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 226 China In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 227 China GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 228 China Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 229 China Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 230 China Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 231 China Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 232 China Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 233 India In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 234 India Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 235 India Non-rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)
  • Table 236 India In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 237 India Autoimmune Conditions based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 238 India Pain management based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 239 India Oncology based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 240 India Solid Tumor based In vivo CRO Market, by Model, 2015 - 2026 (USD Million)
  • Table 241 India CNS based In vivo CRO Market, by Indication, 2015 - 2026 (USD Million)
  • Table 242 India In vivo CRO Market, by GLP Type 2015 - 2026 (USD Million)
  • Table 243 India GLP Toxicology based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 244 India Non-GLP based In vivo CRO Market, by Outsourcing, 2015 - 2026 (USD Million)
  • Table 245 India Rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 246 India Rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 247 India Non-rodent based In vivo CRO Market, by Non GLP type, 2015 - 2026 (USD Million)
  • Table 248 India Non-rodent based In vivo CRO Market, by GLP toxicology, 2015 - 2026 (USD Million)
  • Table 249 South Korea In vivo CRO Market Estimates & Forecasts, by Type, 2014 - 2026 (USD Million)
  • Table 250 South Korea Rodent based In vivo CRO Market, by Type, 2015 - 2026 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 Penetration & growth prospect mapping
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 15 In vivo CRO market Type outlook: Key takeaways
  • Fig. 16 In vivo CRO market: Type movement analysis
  • Fig. 17 Rodent based In vivo GLP Type market, 2015 - 2026 (USD Billion)
  • Fig. 18 Rats based In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 19 Mice based In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 20 Others market, 2015 - 2026 (USD Billion)
  • Fig. 21 Non-rodent based In vivo GLP Type market, 2015 - 2026 (USD Billion)
  • Fig. 22 Hamsters based In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 23 Guinea pigs based In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 24 Gerbils based In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 25 Others based In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 26 In vivo CRO market Application outlook: Key takeaways
  • Fig. 27 In vivo CRO market: Type movement analysis
  • Fig. 28 Non GLP market, 2015 - 2026 (USD Billion)
  • Fig. 29 In house market, 2015 - 2026 (USD Billion)
  • Fig. 30 Outsourcing market, 2015 - 2026 (USD Billion)
  • Fig. 31 GLP toxicology market, 2015 - 2026 (USD Billion)
  • Fig. 32 In house market, 2015 - 2026 (USD Billion)
  • Fig. 33 Outsourcing market, 2015 - 2026 (USD Billion)
  • Fig. 34 In vivo CRO market indication outlook: Key takeaways
  • Fig. 35 In vivo CRO market: Indication movement analysis
  • Fig. 36 Autoimmune/ inflammatory conditions market, 2015 - 2026 (USD Billion)
  • Fig. 37 Rheumatoid arthritis market, 2015 - 2026 (USD Billion)
  • Fig. 38 Multiple sclerosis market, 2015 - 2026 (USD Billion)
  • Fig. 39 Osteoarthritis market, 2015 - 2026 (USD Billion)
  • Fig. 40 Irritable bowel syndrome market, 2015 - 2026 (USD Billion)
  • Fig. 41 Others market, 2015 - 2026 (USD Billion)
  • Fig. 42 Pain management market, 2015 - 2026 (USD Billion)
  • Fig. 43 Chronic pain market, 2015 - 2026 (USD Billion)
  • Fig. 44 Acute pain market, 2015 - 2026 (USD Billion)
  • Fig. 45 Oncology market, 2015 - 2026 (USD Billion)
  • Fig. 46 Blood cancer market, 2015 - 2026 (USD Billion)
  • Fig. 47 Solid tumor market, 2015 - 2026 (USD Billion)
  • Fig. 48 Syngeneic model market, 2015 - 2026 (USD Billion)
  • Fig. 49 Patient derived xenograft market, 2015 - 2026 (USD Billion)
  • Fig. 50 Xenograft market, 2015 - 2026 (USD Billion)
  • Fig. 51 Others market, 2015 - 2026 (USD Billion)
  • Fig. 52 CNS conditions market, 2015 - 2026 (USD Billion)
  • Fig. 53 Epilepsy market, 2015 - 2026 (USD Billion)
  • Fig. 54 Parkinson's disease market, 2015 - 2026 (USD Billion)
  • Fig. 55 Huntington's disease market, 2015 - 2026 (USD Billion)
  • Fig. 56 Stroke market, 2015 - 2026 (USD Billion)
  • Fig. 57 Traumatic brain injury market, 2015 - 2026 (USD Billion)
  • Fig. 58 ALS market, 2015 - 2026 (USD Billion)
  • Fig. 59 Muscle regeneration market, 2015 - 2026 (USD Billion)
  • Fig. 60 Others market, 2015 - 2026 (USD Billion)
  • Fig. 61 Diabetes market, 2015 - 2026 (USD Billion)
  • Fig. 62 Obesity market, 2015 - 2026 (USD Billion)
  • Fig. 63 Others market, 2015 - 2026 (USD Billion)
  • Fig. 64 In vivo CRO market: Crisscross matrix
  • Fig. 65 Non GLP market, 2015 - 2026 (USD Billion)
  • Fig. 66 GLP toxicology market, 2015 - 2026 (USD Billion)
  • Fig. 67 Non GLP market, 2015 - 2026 (USD Billion)
  • Fig. 68 GLP toxicology market, 2015 - 2026 (USD Billion)
  • Fig. 69 Regional market place: Key takeaways
  • Fig. 70 Regional outlook, 2017 & 2026
  • Fig. 71 North America In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 72 U.S. In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 73 Canada In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 74 Europe In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 75 France In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 76 U.K. In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 77 Germany In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 78 Italy In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 79 Spain In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 80 Asia Pacific In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 81 Japan In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 82 China In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 83 India In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 84 Australia In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 85 South Korea In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 86 Latin America In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 87 Brazil In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 88 Mexico In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 89 Argentina In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 90 Colombia In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 91 MEA In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 92 South Africa In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 93 Saudi Arabia In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 94 UAE In vivo CRO market, 2015 - 2026 (USD Billion)
  • Fig. 95 Strategy framework
Back to Top